Production Operator I at Bristol-Myers Squibb

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Previous experience working in a laboratory setting, particularly with pipetting and laminar flow hoods
1 – 4 years’ experience operating in a GMP environment
Experience operating aseptically within ISO 7/Class C strongly preferred
Associate’s or Bachelor’s Degree in a STEM field is preferred
Strong attention to detail and precision in liquid handling
Experience with radiochemistry and/or radiopharmaceuticals strongly preferred
Fluency in English
Strong knowledge of cGMP and aseptic practice
Knowledge of injectable and/or radiopharmaceutical drug product manufacturing
Excellent professional ethics, integrity, and ability to maintain confidential information
Well organized and detail oriented
Strong interpersonal communication skills
Motivated, adaptable

Responsibilities

Execute production of RayzeBio drug products (including raw material preparation, line clearance and cleaning, equipment/instrument setup, etc.) while ensuring compliance with cGMP, aseptic practice, and management expectations
Support and execute validation activities for clinical and commercial manufacturing
Support process improvements, both internally and cross-functionally, as opportunities present
Support department with inventory management, including cleaning supplies and personal protective equipment (PPE)
Support day-to-day production operations, and upkeep of the production area
Promote a culture of safety and compliance with EHS and Radiation Safety programs

Skills

GMP Compliance

Aseptic Processing

Radiation Safety

Batch Production

Radiopharmaceutical Manufacturing

Production Operations

Manufacturing Compliance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free